MedAcuity and Haply Robotics have entered into a strategic partnership to drive forward innovation in precision haptics for medical and robotic technologies. By combining Haply's pioneering haptic interface solutions with MedAcuity's expertise in regulatory-grade software development, the collaboration will focus on creating next-generation teleoperation systems designed for surgical, diagnostic, and simulation use. The partnership aims to deliver real-time, high-accuracy tactile feedback systems that enhance control, safety, and performance across remote medical and robotic applications.
MedAcuity, a leading software engineering company specialising in complex medical and robotic systems, has announced a strategic partnership with Montréal-based Haply Robotics, a global innovator in haptic and robotic interface technologies. Together, the two firms will accelerate the development of advanced teleoperated systems that unite precision engineering with state-of-the-art haptic feedback, transforming the landscape of remote healthcare, simulation, and training experiences.
The partnership integrates Haply's industry-leading technologies--including the award-winning Inverse3X and MinVerse devices--with MedAcuity's depth of knowledge in software architecture, systems integration, and regulatory-compliant development. By fusing cutting-edge tactile technologies with robust, safety-critical software, the collaboration will deliver systems designed to optimise operator control, fidelity, and reliability in high-stakes scenarios.
"This collaboration represents a natural alignment of strengths," said Dennis Fuccione, President of MedAcuity. "Haply Robotics is at the forefront of human machine interaction, and together, we are poised to push the boundaries of what's possible in remote robotic control and medical device innovation."
"Partnering with MedAcuity allows us to bring our advanced haptic technologies into new domains where precision and reliability are critical," said Colin Gallacher, President of Haply Robotics. "Their proven track record in regulated medical and robotic systems complements our mission to deliver intuitive, tactile experiences that elevate human control in remote environments. Together, we're enabling a new standard for human machine interaction."
Under this collaboration, the companies will jointly develop a portfolio of applications encompassing robotic-assisted surgery, remote diagnostics, and immersive simulation training. Each solution will be built with an emphasis on providing real-time, high-fidelity tactile feedback to enhance user precision, responsiveness, and confidence.
As industries increasingly demand more intuitive and responsive human–robot interfaces--particularly within telemedicine, defence, and industrial automation--the MedAcuity–Haply partnership is well-positioned to lead the next phase of innovation in haptic and teleoperated technologies.
source:newsreleases.co.uk
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch